Single-dose azithromycin for genital lymphogranuloma venereum biovar Chlamydia trachomatis infection in HIV-infected women in South Africa : an observational study
Loading...
Date
Authors
Peters, Remco P.H.
Maduna, Liteboho Daniel
Kock, Marleen M.
McIntyre, James A.
Klausner, Jeffrey D
Medina‑Marino, Andrew
Journal Title
Journal ISSN
Volume Title
Publisher
Lippincott Williams and Wilkins
Abstract
We conducted an observational study of lymphogranuloma venereum (LGV) biovar Chlamydia trachomatis infection in HIV-infected women in South Africa. The LGV biovar was detected in vaginal specimens of 17 (20%) of 85 women with C. trachomatis infection; 29% were symptomatic. All cases were negative for the LGV biovar after single-dose azithromycin.
Description
Keywords
Lymphogranuloma venereum (LGV), Chlamydia trachomatis (CT), Infection, Human immunodeficiency virus (HIV), Women living with HIV (WLHIV), South Africa (SA), LGV biovar
Sustainable Development Goals
Citation
Peters, R.P.H., Maduna, L., Kock, M.M. et al. 2021, 'Single-dose azithromycin for genital lymphogranuloma venereum biovar Chlamydia trachomatis infection in HIV-infected women in South Africa: an observational study', Sexually Transmitted Diseases, vol. 48, no. 2, pp. e15-e17,
doi: 10.1097/OLQ.0000000000001243.